Loading…
Ginkgo Bioworks provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests, and secured access to at least 10 million rapid antigen test kits.
Ginkgo Bioworks announced a five-year collaboration with Transcriptic valued at more than $10 million to incorporate Transcriptic's robotic automation software into its Boston foundries. Transcriptic engineers will work on-site at Ginkgo.